PacBio's Advanced Sequencing Solutions Enable Breakthrough in Understanding Rare Mendelian Condition
PacBio announced its involvement in a groundbreaking study published in Nature Genetics, which utilized its advanced sequencing technology to explore the genetic basis of a rare Mendelian condition in ...
New addition to PacBio Compatible program enables scientists to connect genetic variation with gene regulation in a single assay, advancing research in rare disease and cancer MENLO PARK, Calif., Sept ...
PacBio and EpiCypher partner to accelerate epigenomics with the Fiber-Seq workflow. The deal combines PacBio's HiFi sequencing with EpiCypher's chromatin expertise. Fiber-Seq links genetic and ...
MENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the ...
MENLO PARK, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (PACB), developer of the world's most advanced sequencing technologies, today announced innovations to its Revio and Vega platforms ...
PACB launched SPRQ-Nx and multi-use SMRT Cells for Revio, lowering sequencing costs by about 30%. PacBio says SPRQ-Nx can push human genome sequencing costs below $300 at scale. PACB upgraded ...
Recent advancements in single-molecule, long-read sequencing (LRS) technologies, developed by companies such as Oxford Nanopore Technologies (ONT) and Pacific Biosciences (PacBio), have substantially ...
MAS-Seq Supports Isoform Research Using Single-Cell RNA Sequencing from 10x Genomics MENLO PARK, Calif., Oct. 20, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, ...
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, announced an expanded partnership with seqWell yesterday. Under the new agreement, PacBio will distribute seqWell’s LongPlex ...
Hosted on MSN
PacBio (PACB) Stock Is Up, What You Need To Know
Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 2% in the pre market session after the stock extended its positive momentum as the company partnered with DKSH and ...
PacBio reports that through its partnership with China-headquartered Berry Genomics, the Sequel II CNDx system has received Class III Medical Device Registration approval from the National Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results